2018
DOI: 10.1016/j.jvs.2017.08.100
|View full text |Cite
|
Sign up to set email alerts
|

Regarding “Cryopreserved venous allograft is an acceptable conduit in patients with current or prior angioaccess graft infection”

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 5 publications
(10 reference statements)
0
2
0
Order By: Relevance
“…4,34,35 But, the patient may develop specific antibodies, which may impact the future organ transplantation. 3638…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…4,34,35 But, the patient may develop specific antibodies, which may impact the future organ transplantation. 3638…”
Section: Discussionmentioning
confidence: 99%
“…4,34,35 But, the patient may develop specific antibodies, which may impact the future organ transplantation. [36][37][38] Given the limitations of cryopreservation for vascular grafts, other techniques have been explored in animal models. Fahner et al demonstrated that preservation of arterial allografts with glycerol is a feasible method in a large animal model with decreased intimal hyperplasia and renewed contraction and relaxation capability of the vessel wall in comparison with UW solution.…”
Section: Discussionmentioning
confidence: 99%